176 related articles for article (PubMed ID: 29531259)
1. Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation.
Bort A; Quesada S; Ramos-Torres Á; Gargantilla M; Priego EM; Raynal S; Lepifre F; Gasalla JM; Rodriguez-Henche N; Castro A; Díaz-Laviada I
Sci Rep; 2018 Mar; 8(1):4370. PubMed ID: 29531259
[TBL] [Abstract][Full Text] [Related]
2. Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors.
Matheson CJ; Casalvieri KA; Backos DS; Minhajuddin M; Jordan CT; Reigan P
Eur J Med Chem; 2020 Jul; 197():112316. PubMed ID: 32334266
[TBL] [Abstract][Full Text] [Related]
3. Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators.
Dokla EM; Fang CS; Lai PT; Kulp SK; Serya RA; Ismail NS; Abouzid KA; Chen CS
ChemMedChem; 2015 Nov; 10(11):1915-23. PubMed ID: 26350292
[TBL] [Abstract][Full Text] [Related]
4. Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells.
Akasaka Y; Hasei S; Ohata Y; Kanna M; Nakatsu Y; Sakoda H; Fujishiro M; Kushiyama A; Ono H; Matsubara A; Hinata N; Asano T; Yamamotoya T
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958994
[No Abstract] [Full Text] [Related]
5. Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
Chen D; Banerjee S; Cui QC; Kong D; Sarkar FH; Dou QP
PLoS One; 2012; 7(10):e47186. PubMed ID: 23056607
[TBL] [Abstract][Full Text] [Related]
6. Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK).
Draz H; Goldberg AA; Titorenko VI; Tomlinson Guns ES; Safe SH; Sanderson JT
Cell Signal; 2017 Dec; 40():172-182. PubMed ID: 28923415
[TBL] [Abstract][Full Text] [Related]
7. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
[TBL] [Abstract][Full Text] [Related]
8. Alternol exerts prostate-selective antitumor effects through modulations of the AMPK signaling pathway.
Yeung ED; Morrison A; Plumeri D; Wang J; Tong C; Yan X; Li J
Prostate; 2012 Feb; 72(2):165-72. PubMed ID: 21538425
[TBL] [Abstract][Full Text] [Related]
9. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.
Tennakoon JB; Shi Y; Han JJ; Tsouko E; White MA; Burns AR; Zhang A; Xia X; Ilkayeva OR; Xin L; Ittmann MM; Rick FG; Schally AV; Frigo DE
Oncogene; 2014 Nov; 33(45):5251-61. PubMed ID: 24186207
[TBL] [Abstract][Full Text] [Related]
10. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
11. AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Böttcher K; Longato L; Marrone G; Mazza G; Ghemtio L; Hall A; Luong TV; Caruso S; Viollet B; Zucman-Rossi J; Pinzani M; Rombouts K
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G543-G556. PubMed ID: 33406006
[TBL] [Abstract][Full Text] [Related]
12. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.
Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A
Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355
[TBL] [Abstract][Full Text] [Related]
13. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Autophagy Promotes Hemistepsin A-Induced Apoptosis via Reactive Oxygen Species-Mediated AMPK-Dependent Signaling in Human Prostate Cancer Cells.
Kim KY; Yun UJ; Yeom SH; Kim SC; Lee HJ; Ahn SC; Park KI; Kim YW
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944451
[TBL] [Abstract][Full Text] [Related]
15. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation.
Lee YK; Lee WS; Kim GS; Park OJ
Oncol Rep; 2010 Dec; 24(6):1471-7. PubMed ID: 21042741
[TBL] [Abstract][Full Text] [Related]
16. The depletion of cellular ATP by AG2034 mediates cell death or cytostasis in a hypoxanthine-dependent manner in human prostate cancer cells.
Obajimi O; Melera PW
Cancer Chemother Pharmacol; 2008 Jul; 62(2):215-26. PubMed ID: 17896107
[TBL] [Abstract][Full Text] [Related]
17. Triptolide induces protective autophagy through activation of the CaMKKβ-AMPK signaling pathway in prostate cancer cells.
Zhao F; Huang W; Zhang Z; Mao L; Han Y; Yan J; Lei M
Oncotarget; 2016 Feb; 7(5):5366-82. PubMed ID: 26734992
[TBL] [Abstract][Full Text] [Related]
18. Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer.
Kuramoto K; Yamada H; Shin T; Sawada Y; Azami H; Yamada T; Nagashima T; Ohnuki K
Bioorg Med Chem; 2020 Mar; 28(5):115307. PubMed ID: 32007387
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
20. The interplay of AMP-activated protein kinase and androgen receptor in prostate cancer cells.
Shen M; Zhang Z; Ratnam M; Dou QP
J Cell Physiol; 2014 Jun; 229(6):688-95. PubMed ID: 24129850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
